Patent · US Active

Prodrugs of oxazolidinone CETP inhibitors

US8354454B2 · kind B2 · utility

7Cited by

4References

17Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Sander G. Mills · Scotch Plains, US
Amjad Ali · Freehold, US
Cameron Smith · Lawrenceville, US

Key dates

Filing date	Sep 21, 2009
Grant date	Jan 15, 2013
Priority date	—
Expiry date	Dec 20, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The compounds of Formula I are pro-drugs of CETP inhibitors having a central oxazolidinone ring. The compounds cyclize by the elimination of HX to form an oxazolidinone ring after administration to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.